Advances in multiparameter optimization methods forde novodrug design-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in multiparameter optimization methods forde novodrug design

Published:2014-05-03 Issue:7 Volume:9 Page:803-817
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Segall Matthew

Publisher

Informa Healthcare

Subject

Drug Discovery

Link

http://www.tandfonline.com/doi/pdf/10.1517/17460441.2014.913565

Reference65 articles.

1. Can the pharmaceutical industry reduce attrition rates?

2. How to improve R&D productivity: the pharmaceutical industry's grand challenge

3. Managing the drug discovery/development interface

4. High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Role of Artificial Intelligence and Machine Learning in Pharmaceutical Formulation Design;International Journal of Newgen Research in Pharmacy & Healthcare;2024-06-30

2. The Role of AI in Drug Discovery;ChemBioChem;2024-06-26

3. Revolutionizing Drug Discovery: A Comprehensive Review of AI Applications;Drugs and Drug Candidates;2024-02-13

4. OptADMET: a web-based tool for substructure modifications to improve ADMET properties of lead compounds;Nature Protocols;2024-01-23

5. Chembr: A Novel Generative Model Based on Bidirectional Molecular Ring Constraints;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3